Skip to content
★ Sign in to follow
KY

Kathy Yi

Sangamo Therapeutics, Inc
Total declarations
33
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (15 ops.)
€899k

Latest filing published 17 May 2019 for Sangamo Therapeutics, INC, €20k.

Filing timeline

BuySale
Kathy Yi

Insider track record

Disclosed buys
0
Disclosed sells
15
Signal history

No signal scores available.

Kathy Yi: trading record in brief

This profile gathers the share dealings of Kathy Yi in Sangamo Therapeutics, Inc. In total, 33 filings cover trades dated from 24 January 2018 to 15 May 2019.

Every open-market trade on record is a sale: 15 sales worth €899k. The rest of the record consists of 3 share grants and 15 option exercises. Since January 2019: no purchases and 5 sales on the market.

The newest entry dates from 17 May 2019: an open-market sale of €45k, in Sangamo Therapeutics, Inc. Typically, a trade is published a median of 1 day after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Kathy Yi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations33 total
  • ◇
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-19-031065:0
  • ▼
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    50,000 USD0SEC
    5,000 shares@ US$10.00Common StockSEC:0001209191-19-031065:1
  • ◇
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-19-024836:0
  • ▼
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    60,550 USD0SEC
    5,000 shares@ US$12.11Common StockSEC:0001209191-19-024836:1
  • ◇
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-19-020126:0
  • ▼
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    50,000 USD0SEC
    5,000 shares@ US$10.00Common StockSEC:0001209191-19-020126:1
  • ◇
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-19-017164:0
  • ▼
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    50,000 USD0SEC
    5,000 shares@ US$10.00Common StockSEC:0001209191-19-017164:1
  • ◆
    EVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    0SEC
    19,250 shares0Common StockSEC:0001209191-19-014297:0
  • ◆
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    10,967 USD0SEC
    988 shares@ US$11.10Common StockSEC:0001209191-19-005619:0
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-19-003926:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    55,200 USD0SEC
    5,000 shares@ US$11.04Common StockSEC:0001209191-19-003926:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-063265:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    57,200 USD0SEC
    5,000 shares@ US$11.44Common StockSEC:0001209191-18-063265:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-059015:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    50,000 USD0SEC
    5,000 shares@ US$10.00Common StockSEC:0001209191-18-059015:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-055200:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    69,850 USD0SEC
    5,000 shares@ US$13.97Common StockSEC:0001209191-18-055200:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-051500:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    73,300 USD0SEC
    5,000 shares@ US$14.66Common StockSEC:0001209191-18-051500:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-047359:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    76,950 USD0SEC
    5,000 shares@ US$15.39Common StockSEC:0001209191-18-047359:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-042845:0
  • ▼
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    73,850 USD0SEC
    5,000 shares@ US$14.77Common StockSEC:0001209191-18-042845:1
  • ◇
    SVP & Chief Financial OfficerExecutivesSangamo Therapeutics, Inc
    22,750 USD0SEC
    5,000 shares@ US$4.55Common StockSEC:0001209191-18-038208:0

25 of 33 declarations